Seres Therapeutics, Inc.MCRBNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 33 | 145↑336.3% | 0 | 0 | 0 |
| Gross Profit | -57 | 145↑352.7% | 0 | 0 | -4 |
| Operating Income | -88 | -64↑26.8% | -180↓179.0% | -195↓8.4% | -121↑37.8% |
| Net Income | -89 | -66↑26.4% | -250↓281.5% | -114↑54.5% | 0↑100.1% |
| EBITDA | -77 | -57↑26.6% | -171↓201.4% | -181↓6.1% | -120↑33.7% |
| EPS Diluted | -22.34 | -14.30↑36.0% | -46.29↓223.7% | -17.77↑61.6% | -18.86↓6.2% |